Who Will Hold the Reins? An Analysis of Drug-Originating Countries for the US Market
This analysis reveals a paradox: 85% of APIs for U.S. branded drugs are imported (43% from Europe). Proposed tariffs threaten global supply chains, forcing pharmaceutical companies to restructure sourcing strategies.
June 19, 2025
by N55.6761
Is the Practice of "Prioritizing Biologics over Small Molecule Drugs" Justified?
The article compares small molecule drugs and biologics in development, cost, etc., questions biologic - preferential policies, and mentions related acts for policy correction.
March 14, 2025
by Krebs Qin
What’s the known so far with Medicines & Good Manufacturing Practices?
Be it a pharmaceutical or bio-pharmaceutical, both are regulated by the FDA, US. And it is mandatory for both kinds of manufacturing companies to follow the current Good manufacturing practices (cGMP) inprocess of getting certified from USFDA.
May 16, 2023
by Shruti Talashi
Pharma Budget 2022
Pharma leaders and experts share their concerns about the industry, and expectations from Budget 2022.
January 19, 2022
by ExpressPharma
Lundbeck trims full-year sales outlook as Northera generics bite
CEO Deborah Dunsire said growth of Lundbeck's strategic brands in the second-quarter has been accelerating post-pandemic, recording double-digit gains again "as we begin to see more normalised interaction between physicians and patients."
August 19, 2021
by firstwordpharma
Continuous Manufacturing Part 1: Advantages to Drug Companies to Approach Continuous Manufacturing
Learning what are the features attracting big pharma and generic companies to approach Continuous Manufacturing process from Batch Manufacturing process by reading Dr. Deepak Hegde's Continuous Manufacturing series articles.
March 11, 2021
by Deepak Hegde
Pharmaceutical Manufacturers Establish Coalition to Raise Awareness of Authorized Generics
Pharmaceutical manufacturers announced the formation of a coalition that will raise awareness of the category of Authorized Generic medicines.
November 13, 2020
by americanpharmaceuticalreview
Jan Aushadhi stores selling branded generics instead of pure generics: Karnataka Pharmacists Association
The association has also raised concerns about the sale of medicines in the absence of registered pharmacists which may lead to adverse effects.
August 21, 2020
by expresspharma
FDA approves first generics of Gilenya
The US Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.
December 9, 2019
by expresspharma
Biologics and generics reported to save NHS £700m
An NHS-wide plan to use more generic and biologic products has reportedly saved the healthcare provider £700 million since 2016.
September 3, 2019
by europeanpharmaceuticalreview
Endo Appoints EVP and CCO, Sterile and Generics
Ciarico to lead commercial strategy and execution for Endo's Generics Pharmaceutical and Sterile Injectable businesses.
August 2, 2019
by contractpharma
Drive for generics sees Korea increasingly attractive to international pharma
CPhI Korea data shows an increase in ‘overall competitiveness’
August 1, 2019
by biospectrumasia